ライフサイエンスコーパス: bacteriuria

1 ctal swabs; with separate subanalysis on GBS bacteriuria).

2 re there is evidence of ascending infection (bacteriuria).

3 eceived quinolones in the 6 months preceding bacteriuria.

4 re testing for and treatment of asymptomatic bacteriuria.

5 tested for bacteremia within +/-1 day of the bacteriuria.

6 of chronic cystitis as defined by persistent bacteriuria.

7 fits and harms of screening for asymptomatic bacteriuria.

8 re similar children with quinolone-sensitive bacteriuria.

9 -1.43 increased odds for quinolone-resistant bacteriuria.

10 to a hypothetical patient with asymptomatic bacteriuria.

11 it were asymptomatic patients with recurrent bacteriuria.

12 43.9% were due to treatment of asymptomatic bacteriuria.

13 scribe antibiotic treatment for asymptomatic bacteriuria.

14 ization that is associated with asymptomatic bacteriuria.

15 ly to prescribe antibiotics for asymptomatic bacteriuria.

16 ss to prescribe antibiotics for asymptomatic bacteriuria.

17 eceived quinolones in the 6 months preceding bacteriuria.

18 re similar children with quinolone sensitive bacteriuria.

19 -1.43 increased odds for quinolone-resistant bacteriuria.

20 ly 4.7% of repeat cultures were positive for bacteriuria.

21 an independent risk factor for Enterococcus bacteriuria.

22 acquired, gram-negative quinolone-resistant bacteriuria.

23 acquired, gram-negative quinolone resistant bacteriuria.

24 , this treatment failed to prevent relapsing bacteriuria.

25 events the development of relapsing bouts of bacteriuria.

26 43.9% were due to treatment of asymptomatic bacteriuria.

27 rgo screening and treatment for asymptomatic bacteriuria.

28 ociated with UTI episodes and with levels of bacteriuria.

29 rains (53% of isolates) than in asymptomatic bacteriuria (32%) or fecal/commensal (12.5%) strains.

30 mensal, 32 animal commensal, 54 asymptomatic bacteriuria, 45 complicated UTI, 38 uncomplicated cystit

31 in those associated with catheter-associated bacteriuria (58%) and in fecal strains (22%) (P < 0.001)

32 Among 2225 episodes of bacteriuria, 64% were classified as ASB.

33 ovariectomized mice had significantly higher bacteriuria, a more robust inflammatory response, and in

34 inary tract infection (UTI) and asymptomatic bacteriuria (AB) in relation to diabetes mellitus and it

35 ce and clinical significance of asymptomatic bacteriuria (AB) in women with autoimmune rheumatic dise

36 ttle is known about the role of asymptomatic bacteriuria (AB) treatment in young women affected by re

37 UTIs) are routinely treated for asymptomatic bacteriuria (AB), but the consequences of this procedure

38 inoculation with the prototype asymptomatic bacteriuria (ABU) strain E. coli 83972, and inhibition w

39 about bacteria associated with asymptomatic bacteriuria (ABU) with regard to urinary tract colonizat

40 oli isolates from patients with asymptomatic bacteriuria (ABU).

41 s both symptomatic cystitis and asymptomatic bacteriuria (ABU); however, growth characteristics of S.

42 screening for and treatment of asymptomatic bacteriuria aid in antibiotic stewardship.

43 have the highest prevalence of asymptomatic bacteriuria, although rates increase with age among both

44 The majority of bacteriuria among inpatient veterans is due to ASB with

45 We investigated the prevalence of bacteriuria among pregnant women with and without UTI sy

46 ct confounding due to untreated asymptomatic bacteriuria among women who were not given a diagnosis o

47 rther assess the effect of decolonisation on bacteriuria and candiduria in patients admitted to ICUs.

48 d patients: catheter-associated asymptomatic bacteriuria and catheter-associated urinary tract infect

49 Experimental delineation of asymptomatic bacteriuria and CAUTI informs different strategies for t

50 y described a male patient with asymptomatic bacteriuria and changes in urine character.

51 d by an increased prevalence of asymptomatic bacteriuria and frequent use of urinary catheters.

52 Asymptomatic bacteriuria and pyuria in healthy women often trigger in

53 e prevalence and persistence of asymptomatic bacteriuria and pyuria in women at high risk of recurren

54 Asymptomatic bacteriuria and symptomatic urinary tract infections (UT

55 Low-level bacteriuria and the presence of fastidious organisms are

56 the gut microbiota and future development of bacteriuria and urinary tract infection (UTI).

57 s an independent risk factor for Escherichia bacteriuria and UTI and a 1% relative gut abundance of E

58 s, 49 from patients with catheter-associated bacteriuria, and 27 from fecal samples).

59 Hospitalized adults with pyuria, bacteriuria, and signs and symptoms of complicated urina

60 alaria prevention, treatment of asymptomatic bacteriuria, and treatment of syphilis), if fully implem

61 r period were grouped according to symptoms, bacteriuria, and urinalysis.

62 Trial evidence on harms of asymptomatic bacteriuria antibiotic treatment was limited.

63 nization, which is analogous to asymptomatic bacteriuria, are independent events that require distinc

64 sions on which a culture showed asymptomatic bacteriuria, as compared with 1 percent of occasions whe

65 gic evaluation of patients with asymptomatic bacteriuria, as well as indications for antibiotic treat

66 ic overuse through treatment of asymptomatic bacteriuria (ASB) and long durations of therapy for symp

67 Differential diagnosis of asymptomatic bacteriuria (ASB) and urinary tract infection (UTI) is b

68 contamination, but the role of asymptomatic bacteriuria (ASB) before elective surgery and the subseq

69 ent, and the high prevalence of asymptomatic bacteriuria (ASB) complicate the diagnosis of urinary tr

70 Asymptomatic bacteriuria (ASB) is a common finding in many population

71 Antibiotic stewardship for asymptomatic bacteriuria (ASB) is an important quality improvement ta

72 y symptoms are often absent and asymptomatic bacteriuria (ASB) is prevalent.

73 y symptoms are often absent and asymptomatic bacteriuria (ASB) is prevalent.

74 Hospitalized patients with asymptomatic bacteriuria (ASB) often receive unnecessary antibiotic t

75 tial treatment for lower UTI or asymptomatic bacteriuria (ASB) or as stepdown treatment for upper UTI

76 was driven by a higher rate of asymptomatic bacteriuria (ASB) post-treatment in patients on sulopene

77 with the clinical condition of asymptomatic bacteriuria (ASB), characterized by significant bacteria

78 mend withholding antibiotics in asymptomatic bacteriuria (ASB), including among patients with altered

79 tract in a phenomenon known as asymptomatic bacteriuria (ASB).

80 person-years; RR, 0.67; 95% CI, 0.32-1.40), bacteriuria associated with multidrug-resistant gram-neg

81 human bladder with a prototypic asymptomatic bacteriuria-associated bacterium, Escherichia coli 83972

82 The sensitivities for Gram-negative bacteriuria at >/=10(4) CFU/ml and >/=10(5) CFU/ml were

83 of cultures) were not predictive of bladder bacteriuria at any colony count (Spearman's r=0.322 for

84 t significantly decreases candiduria and any bacteriuria, but not for women.

85 XGBoost could accurately predict bacteriuria by using only data that were available durin

86 hine learning model could accurately predict bacteriuria by using only the data that are readily avai

87 Screening for asymptomatic bacteriuria can identify patients for whom treatment mig

88 at treatment of screen-detected asymptomatic bacteriuria can reduce the incidence of pyelonephritis i

89 ibiotic consumption and an increased risk of bacteriuria caused by fluoroquinolone-resistant E coli.

90 Bacteriuria commonly precedes UTI and is often treated w

91 hereas recurrent infections and asymptomatic bacteriuria commonly result from urinary tract malformat

92 Bacteriuria contributes to antibiotic overuse through tr

93 Conversely, overtreatment of false positive bacteriuria could lead to adverse effects from antibioti

94 ix months for the occurrence of asymptomatic bacteriuria (defined as at least 10(5) colony-forming un

95 5 (sensitivity 86%) samples with significant bacteriuria, defined as the presence of a Gram-negative

96 Enterococcus faecalis, and Candida albicans (bacteriuria developed at a mean of 2-5 days vs. 9-34 day

97 We tested RapidBac, a rapid immunoassay for bacteriuria developed by Silver Lake Research Corporatio

98 phore systems was associated with increasing bacteriuria during cystitis.

99 Screening and treatment for asymptomatic bacteriuria during pregnancy was associated with reduced

100 tream urine was highly predictive of bladder bacteriuria even at very low counts, with a positive pre

101 Asymptomatic bacteriuria events (urine cultures with colony count 105

102 Asymptomatic bacteriuria events were most commonly caused by Escheric

103 te pyelonephritis, while other patients with bacteriuria exhibit an asymptomatic carrier state simila

104 e asymptomatic young women with demonstrated bacteriuria from January 2005 to December 2009 were pros

105 nt evidence helps differentiate asymptomatic bacteriuria from symptomatic UTI.

106 rUTI, with similar increases in same-strain bacteriuria (from 7% to 69%), leukocyte esterase (from 3

107 Outcomes included high-level bacteriuria (>/=50 000 colony forming units [CFU]/mL) wi

108 cystitis, which is manifested as persistent bacteriuria, high bladder bacterial burdens, and chronic

109 chronic cystitis, manifesting as persistent bacteriuria, high-titer bladder bacterial burdens, and c

110 Main Outcomes and Measures: Presence of bacteriuria (ie, at least 105 colony-forming units [CFUs

111 ensitivity and specificity for gram-positive bacteriuria in 404 urine specimens were 91.2 and 99.2%,

112 f high-count (>/=10(4) CFU/ml) gram-negative bacteriuria in 487 urine specimens were 98.2 and 97.4%,

113 e pyuria in 19 cases (11%), and no pyuria or bacteriuria in 9 cases (5%).

114 treptococcus is significant for asymptomatic bacteriuria in a pregnant woman.

115 be antibiotics for treatment of asymptomatic bacteriuria in an effort to reduce infection risk.

116 iuria (the proportion of urine cultures with bacteriuria in asymptomatic women) was 5 percent (95 per

117 ), catheter-associated UTI, and asymptomatic bacteriuria in both women and men.

118 Preterm birth was associated with GBS bacteriuria in cohort studies (RR, 1.98 [95% CI, 1.45-2.

119 guidelines recommend screening and treating bacteriuria in early pregnancy given that urinary tract

120 antimicrobial urinary catheters can prevent bacteriuria in hospitalized patients during short-term c

121 screening for and treatment of asymptomatic bacteriuria in nonpregnant adults has no net benefit.

122 ecommends against screening for asymptomatic bacteriuria in nonpregnant adults.

123 ecommends against screening for asymptomatic bacteriuria in nonpregnant adults.

124 Asymptomatic bacteriuria in older women should not be treated.

125 screening for and treatment of asymptomatic bacteriuria in pregnant persons has moderate net benefit

126 tinues to support screening for asymptomatic bacteriuria in pregnant women, but not in other groups o

127 We analyzed the presence of bacteriuria in relation to the clinical symptoms.

128 ared to the standard streak method to detect bacteriuria in specimens submitted to the diagnostic lab

129 scribe antibiotic treatment for asymptomatic bacteriuria in the absence of an indication.

130 priate antibiotic treatment for asymptomatic bacteriuria in the absence of risk factors.

131 on, which may suggest the triggering role of bacteriuria in the occurrence of edematous episodes.

132 e was driven by a lower rate of asymptomatic bacteriuria in the subgroup of ertapenem-treated patient

133 tinely screened and treated for asymptomatic bacteriuria in the United States.

134 Our study intended to evaluate bacteriuria in the urinalysis of patients with C1-INH-HA

135 UTIs, driven by a lower rate of asymptomatic bacteriuria in those who received ciprofloxacin.

136 tive value of 98% for clinically significant bacteriuria in voided urine and 95% for catheterized uri

137 Asymptomatic bacteriuria in young women is common but rarely persists

138 mes in the setting of untreated asymptomatic bacteriuria include pregnant women and patients who unde

139 ms associated with treatment of asymptomatic bacteriuria (including adverse effects of antibiotic tre

140 ysis for trauma patients with no evidence of bacteriuria, including those who suffered mucosal injuri

141 Chronic bacteriuria is a common occurrence among spinal-cord inj

142 narrow-spectrum antibiotic, and asymptomatic bacteriuria is best left untreated.

143 Asymptomatic bacteriuria is common in young women, but little is know

144 Asymptomatic bacteriuria is common, and screening for this condition

145 Asymptomatic bacteriuria is defined as two consecutive voided specime

146 d the clinical significance of polymicrobial bacteriuria is not fully understood.

147 Antibiotic treatment for asymptomatic bacteriuria is not recommended in guidelines but is a ma

148 Screening and treatment of asymptomatic bacteriuria is not recommended in the following patient

149 Asymptomatic bacteriuria is present in an estimated 1% to 6% of preme

150 Asymptomatic bacteriuria is transient in older women, often resolves

151 urrent urinary tract infection, asymptomatic bacteriuria is uncommon and, when present, rarely lasts

152 regnant women with diabetes for asymptomatic bacteriuria is unlikely to produce benefits.

153 tis), lower UTI (cystitis), and asymptomatic bacteriuria, is useful for numerous reasons, mainly beca

154 E. coli 83972 is an asymptomatic bacteriuria isolate successfully used as a prophylactic

155 Low-count gram-negative bacteriuria (<10(4) CFU/ml) was detected by the filter p

156 tions (UTIs), yet large-scale evaluations of bacteriuria management among inpatients are lacking.

157 setting, is very difficult, as asymptomatic bacteriuria may be difficult to differentiate from sympt

158 The RapidBac test for bacteriuria may be effective as an aid in the point-of-c

159 P. mirabilis bacteriuria may lead to acute pyelonephritis, fever, and

160 Atg16L1-deficient mice (Atg16L1(HM)) cleared bacteriuria more rapidly and thoroughly than controls an

161 Asymptomatic bacteriuria occurs, irrespective of pyuria, in the absen

162 cutive urine samples (1.1%): 62 patients had bacteriuria of >10(7) CFU/liter and at least one UTI sym

163 l lower genitourinary tract abnormalities of bacteriuria or bacterial prostatitis by traditional clin

164 ned as isolates associated with asymptomatic bacteriuria or bladder infection (cystitis).

165 w evidence on screening men for asymptomatic bacteriuria or on harms of screening was found.

166 ions not to screen for or treat asymptomatic bacteriuria or pyuria in healthy, nonpregnant women.

167 , is common but infrequently associated with bacteriuria or symptoms.

168 e cystitis, recurrent cystitis, asymptomatic bacteriuria, or pyelonephritis could progress through th

169 cranberry capsules once a day on presence of bacteriuria plus pyuria among women residing in nursing

170 6.4 years [SD, 8.2], 90.3% white, 31.4% with bacteriuria plus pyuria at baseline), 147 completed the

171 omen aged 65 years or older, with or without bacteriuria plus pyuria at baseline, residing in 21 nurs

172 no significant difference in the presence of bacteriuria plus pyuria between the treatment group vs t

173 Unadjusted results showed the presence of bacteriuria plus pyuria in 25.5% (95% CI, 18.6%-33.9%) o

174 Importance: Bacteriuria plus pyuria is highly prevalent among older

175 in no significant difference in presence of bacteriuria plus pyuria over 1 year.

176 lences of periurethral rUTI strain carriage, bacteriuria, pyuria, and intercourse dramatically increa

177 Recurrent UTIs preceded by bacteriuria, pyuria, and symptoms were caused by strains

178 ry tract infection with daily assessments of bacteriuria, pyuria, and urinary symptoms over a 3-month

179 Control group bacteriuria rate, control catheter type (latex vs. silic

180 Staphylococcus aureus bacteriuria (SABU) may represent multiple processes rang

181 Among 12 trials of asymptomatic bacteriuria screening and treatment during pregnancy (n

182 oping symptomatic UTI (primary end point) or bacteriuria (secondary end point) were extracted by usin

183 Asymptomatic bacteriuria should be differentiated from symptomatic UT

184 In general, asymptomatic bacteriuria should not be treated, and treatment of CAUT

185 h a commensal, potentially probiotic E. coli bacteriuria strain.

186 ntly higher (14.51 vs 8.63) in patients with bacteriuria than in those without (P < 0.0001).

187 dematous attacks was higher in patients with bacteriuria than in those without (P = 0.019, P = 0.022,

188 ohort study of adult inpatients with E. coli bacteriuria that were tested for bacteremia within +/-1

189 hereas in cases of cystitis and asymptomatic bacteriuria the focus should be on bladder function.

190 The prevalence of asymptomatic bacteriuria (the proportion of urine cultures with bacte

191 al spectrum of UTIs ranges from asymptomatic bacteriuria, to symptomatic and recurrent UTIs, to sepsi

192 Benefits of asymptomatic bacteriuria treatment in nonpregnant adult populations w

193 Five RCTs of asymptomatic bacteriuria treatment in nonpregnant adults (n = 777) di

194 screening pregnant persons for asymptomatic bacteriuria using urine culture.

195 ive value of pyuria for E. coli asymptomatic bacteriuria was 4%.

196 Asymptomatic bacteriuria was associated with the same risk factors as

197 Bacteremia secondary to E. coli bacteriuria was frequent (15%) in those tested for it.

198 ith 1 percent of occasions when asymptomatic bacteriuria was not found (P<0.001).

199 e test, detecting the absence of significant bacteriuria, was 94%.

200 In patients with bacteriuria, we found a higher incidence of edema format

201 baseline hazard ratios (HRs) for high-level bacteriuria were 1.02 (95% CI 0.88-1.18) for screening o

202 Inpatients with bacteriuria were classified as asymptomatic or symptomat

203 Bacteriuria with any CFU/mL was also reduced in men in t

204 All trials suggested protection against bacteriuria with test catheter use.

205 Persistent asymptomatic bacteriuria with the same E. coli strain was rare.

206 level candiduria (>/=50 000 CFU/mL), and any bacteriuria with uropathogens.

207 lications within 30 days, and bacteremia and bacteriuria within 7 and 30 days postbiopsy.

208 y prolonged gut persistence and high rate of bacteriuria without documented urinary tract infection.

209 ssary antimicrobial therapy for asymptomatic bacteriuria without significant additional laboratory wo

210 antimicrobial prescriptions for asymptomatic bacteriuria, without any significant impact on incidence